Both in Pharmaceuticals
Aquestive Therapeutics vs Relmada Therapeutics
Over the past year AQST returned −37.5% and RLMD returned +50.5%; their daily moves had a correlation of 0.17.
AQST −37.5% RLMD +50.5%Growth of $1, one year, split-adjusted
| Metric | AQST | RLMD |
|---|---|---|
| Price | $3.80 | $4.17 |
| Market cap | $476.9M | $444.8M |
| Today | −2.06% | −2.34% |
| 1 month | −17.6% | +27.1% |
| 6 months | −10.2% | −46.9% |
| Year to date | −41.2% | −13.7% |
| 1 year | −41.4% | +89.5% |
| Revenue growth (YoY) | +38.1% | — |
| Gross margin | 70.9% | — |
| Net margin | −165.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 8.8× | — |
| Net cash | $47.8M | $217.7M |
| Dividend yield | — | — |
| Volatility (60d) | 54.2% | 60.0% |
| Short % of float | 25.6% | 14.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).